Seizert Capital Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5M Buy
159,977
+7,783
+5% +$600K 0.53% 45
2025
Q4
$12.1M Buy
152,194
+1,402
+0.9% +$111K 0.51% 43
2025
Q3
$11.4M Sell
150,792
-3,368
-2% -$231K 0.49% 44
2025
Q2
$10.6M Sell
154,160
-429,981
-74% -$28.2M 0.47% 49
2025
Q1
$39.6M Buy
584,141
+14,614
+3% +$875K 1.81% 28
2024
Q4
$25.6M Buy
569,527
+105,708
+23% +$5.93M 1.15% 36
2024
Q3
$29.2M Buy
463,819
+15,811
+4% +$922K 1.32% 36
2024
Q2
$26.5M Sell
448,008
-15,342
-3% -$960K 1.31% 32
2024
Q1
$37M Buy
463,350
+7,775
+2% +$594K 1.7% 25
2023
Q4
$36M Buy
455,575
+6,422
+1% +$457K 1.82% 22
2023
Q3
$31.4M Buy
449,153
+7,579
+2% +$537K 1.66% 25
2023
Q2
$30.5M Buy
441,574
+99,010
+29% +$7.04M 1.64% 26
2023
Q1
$25.5M Sell
342,564
-3,285
-0.9% -$275K 1.4% 28
2022
Q4
$32.2M Sell
345,849
-746
-0.2% -$72K 1.71% 21
2022
Q3
$33.1M Sell
346,595
-47,212
-12% -$4.67M 1.86% 21
2022
Q2
$36.5M Buy
393,807
+6,778
+2% +$662K 1.94% 18
2022
Q1
$39.2M Sell
387,029
-81,804
-17% -$8.59M 1.8% 23
2021
Q4
$48.4M Sell
468,833
-12,405
-3% -$1.15M 2.16% 14
2021
Q3
$40.8M Buy
481,238
+12,997
+3% +$1.09M 1.87% 19
2021
Q2
$39.1M Buy
468,241
+12,862
+3% +$1.05M 1.86% 20
2021
Q1
$34.3M Sell
455,379
-21,479
-5% -$1.56M 1.79% 18
2020
Q4
$32.6M Sell
476,858
-19,317
-4% -$1.26M 1.9% 14
2020
Q3
$29M Sell
496,175
-1,031
-0.2% -$64.2K 1.9% 20
2020
Q2
$32.3M Buy
497,206
+81,447
+20% +$5.13M 2.19% 18
2020
Q1
$24.7M Sell
415,759
-25,713
-6% -$1.72M 1.82% 20
2019
Q4
$32.8M Sell
441,472
-19,147
-4% -$1.34M 1.63% 23
2019
Q3
$29.1M Sell
460,619
-21,500
-4% -$1.27M 1.46% 29
2019
Q2
$26.3M Sell
482,119
-43,696
-8% -$2.35M 1.29% 31
2019
Q1
$28.4M Buy
525,815
+17,034
+3% +$1.05M 1.27% 33
2018
Q4
$33.3M Buy
508,781
+145,720
+40% +$10.9M 1.5% 23
2018
Q3
$28.6M Buy
363,061
+26,255
+8% +$1.88M 1.05% 40
2018
Q2
$21M Hold
336,806
0.76% 50
2018
Q1
$21M Sell
336,806
-23,073
-6% -$1.66M 0.76% 50
2017
Q4
$26.1M Sell
359,879
-118,322
-25% -$8.6M 0.94% 42
2017
Q3
$38.9M Sell
478,201
-78,448
-14% -$6.21M 1.43% 27
2017
Q2
$44.8M Buy
556,649
+16,177
+3% +$1.28M 1.62% 23
2017
Q1
$42.4M Buy
540,472
+73,797
+16% +$5.89M 1.51% 27
2016
Q4
$36.8M Buy
466,675
+182,107
+64% +$14.7M 1.31% 30
2016
Q3
$25.3M Buy
284,568
+49,351
+21% +$4.66M 0.94% 45
2016
Q2
$22.5M Sell
235,217
-25,939
-10% -$2.59M 0.85% 47
2016
Q1
$27.1M Sell
261,156
-20,076
-7% -$1.95M 0.92% 44
2015
Q4
$27.5M Buy
281,232
+12,713
+5% +$1.25M 0.86% 46
2015
Q3
$25.9M Sell
268,519
-83,069
-24% -$8.73M 0.78% 48
2015
Q2
$36.9M Buy
351,588
+363
+0.1% +$37.1K 0.94% 47
2015
Q1
$36.3M Sell
351,225
-139,853
-28% -$14.2M 0.91% 50
2014
Q4
$47.3M Sell
491,078
-96,683
-16% -$8.52M 1% 47
2014
Q3
$46.8M Buy
587,761
+13,526
+2% +$1.07M 0.94% 50
2014
Q2
$43.3M Buy
574,235
+3,690
+0.6% +$279K 0.86% 50
2014
Q1
$42.7M Sell
570,545
-17,218
-3% -$1.22M 1% 50
2013
Q4
$42.1M Sell
587,763
-9,128
-2% -$586K 1% 50
2013
Q3
$33.9M Sell
596,891
-84,897
-12% -$5.06M 0.92% 51
2013
Q2
$39M Buy
+681,788
New +$39.5M 1.06% 47

Other funds holding CVS

Seizert Capital Partners's CVS Position: Q1 2026 in Review

Seizert Capital Partners increased its CVS Health (CVS) stake by 5.1% in Q1 2026, buying an estimated $600K and bringing the position to 159,977 shares worth $11.5M. The position accounts for 0.53% of the portfolio, ranked #45.

Seizert Capital Partners first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.4M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Seizert Capital Partners held 159,977 shares of CVS Health worth $11.5M as of Q1 2026.
  • Seizert Capital Partners bought 7,783 CVS Health shares in Q1 2026, an estimated $600K.
  • CVS Health made up 0.53% of Seizert Capital Partners's portfolio in Q1 2026, its #45 holding.
  • Seizert Capital Partners first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Seizert Capital Partners's CVS Health position peaked at $48.4M in Q4 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Seizert Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.